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Abstract Guanylate kinase (GK) catalyses the conversion of 
GMP to GTP as part of the cGMP cycle. In mammalian 
phototransduction, this cycle is essential for the regeneration of 
cGMP following its hydrolysis by phosphodiesterase. Mutations 
in different parts of this signalling cascade lead to retinal 
degeneration in humans. Protein studies have localized a locus 
for GK to a region of human chromosome 1 that also contains an 
autosomal recessive form of retinitis pigmentosa (RP12) and 
Usher's type l la  (USH2A). We report the sequence of this 
human GK (GUK1) and a further refinement of its localization to 
1q32-41, placing it in the same interval as USH2A. 
Key words: Guanylate kinase; cGMP cycle; 
Phototransduction; Usher's type 1 la 
I. Introduction 
An integral component of phototransduction in mammals is 
the hydrolysis of cGMP by a cGMP phosphodiesterase, r -
suiting in the closure of cGMP-gated channels in the plasma 
membrane. The cGMP cycle (cGMP-GMP-GDP-GTP-  
cGMP) [1] is required to regenerate this intracellular messen- 
ger so that, in the dark, cGMP concentration returns to its 
original level, allowing the cGMP-gated channels to re-open 
[2]. The production of GDP from GMP and ATP in the cycle 
is catalysed by guanylate kinase (GK, EC 2.7.4.8). Surpris- 
ingly, GK  has not been considered as a candidate gene for 
retinal disease even though mutations in other parts of the 
phototransduction pathway are responsible for both autoso- 
mal recessive [3-5] and dominant forms of retinitis pigmentosa 
[6]. This may reflect the absence of a retinal-specific form of 
this protein and the housekeeping role of the cGMP cycle in 
signal transduction and other cellular processes [7]. 
In mammals, GK activity is encoded by three distinct loci 
[8]. One of these, GUKI ,  was initially assigned to human 
chromosome 1 by isozyme studies of somatic cell hybrids 
[9]. Using a combination of hybrids generated by X-irradia- 
tion and hybrid cell lines that retain different chromosome 1
translocation breakpoints [10,11], this localization was further 
refined to chromosome lq31-1q42 and subsequently con- 
firmed by the identification of a gene dosage effect for the 
GUK1 protein in a patient with a duplication of chromosome 
1 [12]. Since loci for an Usher's syndrome (USH2A) and an 
autosomal recessive retinis pigmentosa (RP12) [13,14] map to 
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this region of chromosome 1, we have evaluated GUK1 as a 
candidate for retinal disease. In this paper, we present the 
cDNA sequence of the human gene and the refinement of 
its location to the distal portion of chromosome 1. 
2. Materials and methods 
2.1. Database searches 
GUK1 ESTs and homologues in other species were identified using 
the ENTREZ document retrieval system available through the Na- 
tional Centre for Biotechnology Information at the National Insti- 
tutes of Health, USA. 
2.2. DNA sequence analysis 
The cDNA clones 172943 and 172478, made available through the 
Image Consortium, were sequenced in their entirety using an auto- 
mated sequencer (ALF express, Pharmacia) and the Autoread se- 
quencing kit (Pharmacia). Genomic DNA fragments were subcloned 
into pBluescript and sequenced using the T7 sequencing kit (Pharma- 
cia). Standard 6% polyacrylamide s quencing gels were used. Partial 
exon-intron structure was determined by computer alignment of the 
genomic sequence with the cDNA sequence. Sequences were aligned 
using ClustalV [15]. 
2.3. Cosmid identification 
Cosmid clones for GUK1 were identified by screening a gridded 
chromosome 1-specific ICRF reference library kindly provided by the 
ICRF reference library system (D. Nizectic, unpublished; [16]). Ap- 
prox. 40 000 clones were screened with a probe of about 700 bp that 
contains the entire coding region of the bovine GUKI cDNA ([17], 
kindly provided by Dr. Yakhyaev at the Shemyakin Institute of 
Bioorganic Chemistry, Moscow). All hybridizations were carried out 
under standard conditions [18]. 
2.4. Subcloning of genomic DNA fragments 
The cosmid clones ICRFc11210445 and ICRFc11200286 were re- 
striction digested with PstI, ApaI, and ApaI-PstI, and the resulting 
fragments were subcloned into the appropriate site of pBluescript KS 
(+). Positive clones were identified by hybridisation screening with a 
:~P-labelled probe that contained the entire coding region of GUK1. 
2.5. Fluorescence in situ hybridisation 
The procedures for fluorescence in situ hybridization (FISH) were 
adapted from the original description by Pinkel et al. [19]. Cosmid 
DNA was prepared from 10 ml bacterial cultures grown overnight at 
37°C, using the Magic Miniprep DNA purification system (Promega). 
Biotin labelled cosmid DNA was hybridized overnight at 37°C to 
human chromosome spreads prepared from normal ymphocyte cul- 
tures, followed by signal detection with avidin-fluorescein isothiocya- 
nate (avidin-FITC). For R-banding, chromosomes were counter- 
stained with propidium iodide and diamidophenylindole (DAPI). A 
dual bypass filter allowed the simultaneous visualisation of signals and 
banded chromosomes. Images were captured and analysed using an 
MRC600 confocal laser attachment. Approx. 20 metaphase chromo- 
some spreads were analysed for accurate assessment of signal ocaliza- 
tion. 
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A~TC~G~CCCAGGC~TGTGGTGCTGAGCGGGCCTT~GGGAGCTGGG~GAG~ACCCTG~GAGG~TG~TCCAGGAGCACAGCGGC 90  
M S G P R P V V L S G P S G A G K S T L L K R L L Q E H S G  30  
ATCTTTGGCTTCAGCG~TCCCATACCACGA~CCCGAGGCCC~GC~AGGA~CGGCAAAGATTACTACTTTGT~CCAGGGAGGT~ 180 
I F G F S V S H T T R N P R P G E E N G K D Y Y F V T R E V  60  
ATGCAGCG~A~ATA~CAGCCGGC~ACTTCATCGAGCA~CC~AGTTCTCGGG~CCTGTATGGCACGAGC~GGTG~C~GTGCAGGCC 270 
M Q R D I A A G D F I E H A E F S G N L Y G T S K V A V Q A 90  
G~CAGGCCATG~CCGCATCTGTGTGCTGGACGTGGACCTGCAGGGTGTGCGG~CATC~GGCCACCGATCTGCGGCCCATCTACATC 360 
V Q A M N R I C V L D V D L Q G V R N I K A T D L R P I Y I 120  
TCTGTGCAGCCGCCTTCACTGCACGTGCTGGAGCAGCGGCTGC~CAGCGC~CACTGAAACCGAGGAGAGCCTGGTG~GCGGCTGGCT 450 
S V Q P P S L H V L E Q R L R Q R N T E T E E S L V K R L A  150 
GCTGCCCAGGCCGACATGGAGAGCAGC~GGAGCCCGGCCTGTTTGATGTGGTCATCATT~CGACAGCCTGGACCAGGCCTACGCAGAG 540 
A A Q A D M E S S K E P G L F D V V I I N D S L D Q A Y A E  180 
CTG~GGAGGCGCTCTCTGAGGAAATC~GAAAGCTCAAAGGA~CGGCGCCtgaggct tgctgtc tgt tc tcggcaccccgggcccatac  630  
L K E A L S E E I K K A Q R T G A * 197  
aggaccagggcagcagcat tgagccaccccct tggcaggcgatacggcagctc tgtgccct tggccagcatgtggagtggaggagatgct  720 
gcccctgtggt tggaacatcc tgggtgacccccgacccagcctcgctgggctgtcccctgtccctatc tc tcactc tggacccagggctg  810 
acatcc taa~aaaataactgt tggat tagaaaaaaaa 847 
Fig. 1. Nucleotide and dedu~d amino acid sequence of the human GUK1 cDNA (GenBank accession o. L76200). The poly(A) addition sig- 
nal and poly(A) tail a~ indicated by sin~e and double underlining, respectively. A 19 bp region that is absent in clones H56620 and T08090 is 
indica~d by a bar above the relevant sequence. 
3. Results and discussion 
3.1. Isolation of the human GUK1 cDNA 
A number of human expressed sequence tag sites (ESTs) 
showing homology to the porcine GK gene were identified 
as part of the Washington-Merck sequencing project (see sec- 
tion 2). Two clones, 172943 (accession o. H20470) and 
172478 (accession o. H20158), made available through the 
Image Consortium, were sequenced in their entirety. The con- 
sensus nucleotide sequence of human GUK1 is shown in Fig. 
1. Comparison of the protein sequence with other mammalian 
GKs suggests that these clones contain the entire coding se- 
quence (Fig. 2). The predicted amino acid sequence is 197 
residues in length, and the resultant polypeptide has an esti- 
mated Mr of approx. 22 kDa. Amino acid alignment with the 
bovine [17], porcine [20], yeast (Saccharomyces cerevisiae) [21], 
and bacterial (E. coli) [22] enzymes give amino acid identity of 
91, 89, 64 and 54%, respectively. All five sequences how 
considerable homology at regions implicated in specific inter- 
actions in yeast GK. The putative ATP-binding site consisting 
of the sequence GxxGxGKS [23] is identical across all five 
species, and with the exception of conservative changes in 
the yeast and bacterial proteins, the Mg 2+ motif [24] and 
the sites of interaction with the guanine ring and phosphate 
groups of GMP [25] are also conserved. There is also a single 
potential N-linked glycosylation site at residue 171 that is 
conserved in all three mammalian proteins. 
We have shown that all available GUKl-related EST clones 
share a common 3' untranslated region (unpublished observa- 
tion). In contrast, the original protein isozyme studies indi- 
cated that GK activity is encoded by three distinct loci that 
code for proteins with Mr of approx. 22, 27 and 32 kDa, 
respectively [8]. This latter study used enzymic staining to 
follow the production of GDP and ADP so it is possible 
that the other proteins with GK activity are specified by ad- 
ditional GK loci that are not closely related to the GUK1 
gene. Two such loci are the genes encoding the p55 membrane 
protein [26] and DLG2 [27], a mammalian homologue of the 
Drosophila tumor suppressor gene dig-A; both contain a GK 
domain that has many of the conserved features of GUK1, 
and it been proposed that these genes may encode proteins 
with GK activity [27-29]. However, since the Mr values of 
these proteins do not correspond to either the 27 or 32 kDa 
sizes of the GK proteins identified from protein isozyme ana- 
lysis [8], it is unlikely that either of the above genes encodes 
the other isozymic variants of GK. 
3.2. Expression analysis of GUK1 
GUK1 has been shown to code for the e, f, and g isozymes 
of guanylate kinase with Mr values of 22, 22.5 and 22.5 kDa, 
respectively [8]. Isozymes e and f are present in almost all 
tissues while isozyme g is restricted to red cells [8]. In red cells, 
there is a reduction with age in the amount of the e isozyme 
present, with an associated increase in the amounts of iSO- 
G P P P 
Human MSGPRPVVLSGPSGAGKSTLLKRLLQEHSG I - FGF SVSHTTRNPRPGEBN 49 
Bov ine  . . . . . . . . . . . . . . . . . . . . . .  K ..... GS. - . . . . . . . . . .  D .. . . . . .  49 
Porc ine  .GS . . . . . . . . . . . . . . . . . . .  K ...... S.-  . . . . . . . . . .  D ....... 49 
Yeast  . . - - . . I . I  ..... T ....... K .FA .YPDS- .  ..... S . . .T . .A . .V ,  47 
Bacter ia l  .AQGTLY IV .A  ....... S . IQA. .KTQPLYDTQV ....... Q ..... VH 50 
P G PG 
Human GKDYYFVTREVMQRD I AAGD F I E HAEF  SGNLYG T SKVAVQAVQAMNR I~ 99 
Bov ine  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  A . .R  . . . . . . . . . .  99 
Porc ine  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  A . .R  . . . . . . . . . .  99 
Yeas  t .... N.. SVDEFKSM.  KNNE. . .  W. Q .... Y.. STVAS. KQ. SKSGKT.  I 97 
Bacter ia l  .EH.F, .NHDEFKEM.SRDA.L . . .EVF . .y  .... RE . IEQ.L .TGVDVF 100 
PGG 
Human LD~LQGVRNIKAT - DLRP IY I SVQP PS LHVLEQRLRQRNTBTEESLV~R 148 
Bov ine  . . . . . . . . . . . .  K.-  ....... F . . . . . . . . . . . . . . . . . . . . . . . .  A.. 148 
Porc ine  . . . . . . . . . . . .  K . - . .Q  .... F ...... D . . . . . . . . . . . . . . . . .  A.. 148 
Yeast  . . I .M... KSV..  I PELNARFLF IA . . .  VED. KK.. EG. G ...... IN.. 147 
Bacter ia l  . . I .W. .AQQ.RQKMP-HA.S .F .L . . .K IE .DE . . .G .GQDS. .V IA . .  149 
Human LAAAQADMES SKEPGLFDVVI  INDSLDQAYAELKEALS EE I KKAQRTG - 196 
Bov ine  .... R . . . . . . . . . . . . .  LI ....... K . .WA . . . . . . . . . . . . .  G . .Q-  197 
Porc ine  .... K . . . . . . . . . . . . .  LI ....... K . .WA . . . . . . . . . . . . .  A . .H -  197 
Yeast  .S .... ELA-YA.T .AH.K . .V . .D . .K .  ,K. . .DFIFA.  - . . . . . . . .  186 
Bacter ia l  M .Q.V .E .SHYA. - - -Y .YL .V . .DF .T .LTD. .T I IRA ,RLRMS.QKQR 196 
Human . . . . . . . . .  A - 197 
Bov ine  . . . . . . . . .  S- 198 
Porc ine  . . . . . . . . .  S- 198 
Yeast  . . . . . . . . . .  K 197 
Bacter ia l  HDAL ISKLL .  D 207 
Fig. 2. Amino acid alignment of guanylate kinases. The ATP and 
Mg 2+ binding motifs are indicated by an overscore and underscore 
respectively. The sites of interaction with the guanine ring and phos- 
phate groups of GMP are indicated by G and P, respectively. The 
single glycosylation site in the three mammalian proteins is identi- 
fied by an asterisk. 
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Fig. 3. (a) Chromosomal localization of GUK1 to human chromo- 
some 1 by FISH. The hybridization signal was assigned to chromo- 
some 1q32-41 (arrowed). Enlargement of both copies of chromo- 
some 1 are also shown. (b) Idiogram of human chromosome lq
showing the position of GUK1 FISH hybridization signals and the 
physical locations of the RP12 and USH2A loci. 
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zymes f and g, indicating that e is the primary form, and that 
it is modified in some manner to produce the two secondary 
isozymes. This posttranslational modification may involve gly- 
cosylation, as a single glycosylation site is conserved in all 
mammalian GUK1 proteins (Fig. 2). 
The broad tissue-expression pattern of the GUK1 protein is 
consistent with the identification of ESTs for GUK1 in retina 
(H95538, H92316), infant and adult brain (H17287, H17288, 
T08090, H19929, H20252, H20158, H40996, H43002), pineal 
gland (H56620), lung (T34435), breast (R54941 ; R54752), foe- 
tal liver-spleen (H38217) and melanocytes (H83699, H97119). 
We have also noted that two ESTs, H56620 and T08090, lack 
a 19 bp region between ucleotides 157 and 176 of the human 
GUK1 cDNA (Fig. 1); the absence of this region results in 
the formation of a truncated protein of 53 amino acids that is 
unlikely to be functionally important. 
3.3. Mapping of human GUK1 to chromosome 1 
A gene coding for a GK has previously been assigned by 
protein studies [9,11,12] to the distal region of the long arm of 
chromosome 1 at q31-42. A full length bovine GK cDNA 
clone [17] was used to screen a human chromosome 1 cosmid 
library [16] and two overlapping postive clones, ICRF- 
c11210445 and ICRFc11200286, were identified. These cos- 
mids were shown by partial sequence analysis of several sub- 
clones to contain the GUK1 gene and from this, we have been 
able to define the exon-intron structure of the 3' end of the 
gene. Two introns were identified after nucleotides 390 and 
476, although it is possible that more 5' introns are also pre- 
sent. 
The genes for an autosomal recessive RP (RP12) and 
USH2A have been localized to chromosome lq31-q32.1 and 
lq41, respectively (Fig. 3b). To determine whether GUK1 is a 
candidate for either of these retinal diseases, the positions of 
ICRFc11210445 and ICRFc11200286 cosmid clones were re- 
fined by fluorescence in situ hybridization to chromosome 
lq32-41 (Fig. 3); this localization is consistent with previous 
mapping studies using the GUKI protein and places the gene 
distal to the region containing the RP12 locus. Further studies 
will be required to evaluate GUK1 as a candidate for 
USH2A. 
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